Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

Circulation

Volumn 107, Issue 24, 2003, Pages 3040-3046

  Scheuermann Freestone, Michaela ^a,b   Madsen, Per L ^a   Manners, David ^a   Blamire, Andrew M ^a   Buckingham, Robin E ^c   Styles, Peter ^a   Radda, George K ^a   Neubauer, Stefan ^b   Clarke, Kieran ^a,d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diabetes mellitus; Fatty acids; Glucose; Metabolism; Spectroscopy

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH ENERGY PHOSPHATE; HUMAN; INFRARED SPECTROPHOTOMETRY; INSULIN METABOLISM; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIUM; OXYGEN; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; REFERENCE VALUES; SPECTROSCOPY, NEAR-INFRARED;

EID: 0038677068     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000072789.89096.10     Document Type: Article

References (23)

1. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract. 1996;31:S3-S13.
2. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes, I: general concepts. Circulation. 2002;105:1727-1733.
3. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668-2673.
4. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 1998;180:53-57.
5. Chatham JC, Seymour A-ML. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res. 2002;55:104-112.
6. Sidell RJ, Cole MA, Draper NJ, et al. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes. 2002;51:1110-1117.
7. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 1997;34:25-33.
8. Tune JD, Yeh C, Setty S, et al. Coronary blood flow control is impaired at rest and during exercise in conscious diabetic dogs. Basic Res Cardiol. 2002;97:248-257.
9. Meyer C, Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol. 1997;80:94A-101A.
10. Iozzo P, Chareonthaitawee P, Rimoldi O, et al. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes. Diabetologia. 2002;45:1404-1409.
11. Baron AD, Laakso M, Brechtel G, et al. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 1991;73:637-643.
12. 1c levels and exercise capacity in diabetic patients. Jpn Heart J. 2001;42:607-616.
13. Estacio RO, Regensteiner JG, Wolfel EE, et al. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care. 1998;21:291-295.
14. Crilley JG, Boehm EA, Rajagopalan B, et al. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardiol. 2000;36:1953-1958.
15. 31P magnetic resonance spectroscopy study. Brain. 1999;122:121-130.
16. Veech RL, Lawson JWR, Cornell NW, et al. Cytosolic phosphorylation potential. J Biol Chem. 1979;254:6538-6547.
17. Madsen PL, Secher NH. Near-infrared oximetry of the brain. Prog Neurobiol. 1999;58:541-560.
18. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190-2196.
19. Boehm EA, Jones BE, Radda GK, et al. Increased uncoupling proteins and decreased efficiency in the palmitate-perfused hyperthyroid rat heart. Am J Physiol. 2001;280:H977-H983.
20. Chatham JC, Gao ZP, Bonen A, et al. Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes. Cardiovasc Res. 1999;43:96-106.
21. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox? Circulation. 2002;106:2760-2763.
22. Mahler RJ, Adler ML. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab. 1999;84:1165-1171.
23. Komiyama T, Shigematsu H, Yasuhara H, et al. Near-infrared spectroscopy grades the severity of intermittent claudication in diabetes more accurately than ankle pressure measurement. Br J Surg. 2000;87:459-466.